Inhibikase Therapeutics, Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG005TP2339
IKT
Inhibikase Therapeutics, Inc.
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Biotechnology
NAME
Inhibikase Therapeutics, Inc.
ISIN
US45719W2052
TICKER
IKT
MIC
XNAS
REUTERS
IKT.OQ
BLOOMBERG
IKT US
F&G:
61
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
According to the transactions reported via the short sale register, 19.948 shares of Inhibikase Therapeutics, Inc. are held by short sellers as of 24.06.2025. The graph shows how the positions have changed in the past. A ranking list and further statistics for US stocks can be found here. You can track the activities of short sellers with a focus on European companies here.
Information on product placements
The information provided in this area is compiled with care and prepared and processed in complex technical process steps. Quality assurance is an integral part of the methods and procedures used. A plausibility check is carried out to the extent that the source data allows. Before further use, especially in the course of any investment decisions, we recommend consulting at least one second independent source for validation.
SMART * AD
P R O D U C T S U G G E S T I O N S
